Key Takeaway:
- GLP-1 drugs like semaglutide may help reduce alcohol addiction alongside proven weight-loss benefits.
- Evidence linking GLP-1 drugs to reduced gambling addiction remains limited and unproven.
- Long-term exposure to salon and auto shop fumes can increase risks of asthma, lung problems, and certain cancers.
Doctors say GLP-1 agonist drugs used for obesity treatment also show strong evidence of reducing alcohol addiction, while early research suggests possible benefits for gambling disorders, though clinical proof remains limited.
The medications, including semaglutide and tirzepatide, are already widely prescribed for weight loss and diabetes management. Medical experts say new studies now indicate the drugs may also reduce harmful alcohol consumption and lower alcohol-related hospitalizations.
In a medical advice column, Dr. Keith Roach said evidence supporting GLP-1 agonists for weight loss remains “very strong,” with about 80% to 90% of patients losing more than 5% of their body weight. He said the benefits often outweigh the risks for people with obesity and related health conditions.
“The evidence for GLP-1 agonists helping with alcohol use disorder is now quite strong,” Roach wrote, citing studies that showed significant reductions in problem drinking and hospital visits tied to alcohol use.
Researchers seek more evidence on gambling disorders
Roach said evidence linking the drugs to reduced gambling addiction remains preliminary. Scientists believe the medications may affect reward pathways in the brain, but large clinical studies have not yet confirmed their effectiveness for gambling disorders.
“There are no strong clinical data at this time supporting the use of GLP-1 Agonist drugs for a gambling disorder,” he said.
Still, physicians may consider the drugs for patients dealing with obesity and alcohol misuse because of their established benefits in both areas. Roach noted that gambling addiction can severely affect a person’s finances and relationships.
The medications also appear to provide cardiovascular benefits. Roach said studies show the drugs reduce the risk of heart disease in people both with and without diabetes, although researchers are still studying the exact mechanisms behind the protection.
“For those of us who lived through the approval of previous weight-loss drugs, which were later found to cause heart damage, the news about heart protection is welcome,” he wrote.
However, he cautioned that the medicines have been in widespread use for less than a decade, making long-term monitoring important.
Workplace chemical fumes raise cancer, asthma risks
In a separate discussion, Roach warned that long-term exposure to fumes in hair salons, nail salons, and automobile repair shops can seriously affect workers’ health.
He said the lungs are the organs most commonly harmed by chemicals such as benzene, formaldehyde, and toluene. Symptoms may include chest tightness, wheezing, and allergic reactions.
“One study found that half of salon technicians were affected,” Roach wrote.
Auto body and paint workers also face elevated risks. According to Roach, workers exposed to such chemicals develop asthma at rates up to 80 times higher than the general population.
The exposure also increases the risk of certain cancers, including leukemia linked to benzene exposure and sinus or nasal cancers associated with formaldehyde.
Roach said personal protective equipment can reduce risks, but many workers fail to use it consistently. He called for improved workplace ventilation and safer chemical alternatives to better protect employees, while broader medical research continues to explore areas like GLP-1 agonist drugs in chronic disease management.
